Skip to main content
PMC home page
The Texas Heart Institute Journal logoLink to The Texas Heart Institute Journal
. 1990;17(2):112–117.

Thromboangiitis Obliterans

Current Perspectives and Future Directions

Azam Ansari 1,2
PMCID: PMC326466  PMID: 15227394

Abstract

Originally described by von Winiwarter in 1879 and by Buerger in 1908, thromboangiitis obliterans became a focus of delayed controversy in the 1960s when its existence as a separate entity came into question. More recently, new information regarding the disease's pathogenesis, as well as a redefinition of its clinical and roentgenographic features, has given further credence to the theory that thromboangiitis obliterans is a distinct clinicopathologic and roentgenographic entity. By critically analyzing both old and new insights, this article assesses the current status and future directions of the disease. (Texas Heart Institute Journal 1990;17:112-7)

Keywords: Thromboangiitis obliterans

Keywords: atherosclerosis obliterans

Keywords: Buerger's disease

Keywords: peripheral vascular disease

Full text

PDF
115

Images in this article

115Image
on p.115
115Image
on p.115

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ABRAMSON D. I., ZAYAS A. M., CANNING J. R., EDINBURG J. J. THROMBOANGIITIS OBLITERANS: A TRUE CLINICAL ENTITY. Am J Cardiol. 1963 Jul;12:107–118. doi: 10.1016/0002-9149(63)90162-0. [DOI] [PubMed] [Google Scholar]
  2. Chopra B. S., Zakariah T., Sodhi J. S., Khanna S. K., Wahi P. L. Thromboangitis obliterans: a clinical study with special emphasis on venous involvement. Angiology. 1976 Feb;27(2):126–132. doi: 10.1177/000331977602700207. [DOI] [PubMed] [Google Scholar]
  3. Fiessinger J. N., Schäfer M. Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis obliterans. The TAO Study. Lancet. 1990 Mar 10;335(8689):555–557. doi: 10.1016/0140-6736(90)90346-7. [DOI] [PubMed] [Google Scholar]
  4. Gulati S. M., Madhra K., Thusoo T. K., Nair S. K., Saha K. Autoantibodies in thromboangiitis obliterans (Buerger's disease). Angiology. 1982 Oct;33(10):642–651. doi: 10.1177/000331978203301003. [DOI] [PubMed] [Google Scholar]
  5. Gulati S. M., Singh K. S., Thusoo T. K., Saha K. Immunological studies in thromboangitis obliterans (Buerger's disease). J Surg Res. 1979 Nov;27(5):287–293. doi: 10.1016/0022-4804(79)90142-2. [DOI] [PubMed] [Google Scholar]
  6. HORWITZ O. Buerger's disease retrieved. Ann Intern Med. 1961 Aug;55:341–344. doi: 10.7326/0003-4819-55-2-341. [DOI] [PubMed] [Google Scholar]
  7. Hill G. L. A rational basis for management of patients with the Buerger syndrome. Br J Surg. 1974 Jun;61(6):476–481. doi: 10.1002/bjs.1800610615. [DOI] [PubMed] [Google Scholar]
  8. Inada K., Kattsumura T. The entity of Buerger's disease. Angiology. 1972 Dec;23(11):668–687. doi: 10.1177/000331977202301106. [DOI] [PubMed] [Google Scholar]
  9. Lambeth J. T., Yong N. K. Arteriographic findings in thromboangiitis obliterans with emphasis on femoropopliteal involvement. Am J Roentgenol Radium Ther Nucl Med. 1970 Jul;109(3):553–562. [PubMed] [Google Scholar]
  10. MCPHERSON J. R., JUERGENS J. L., GIFFORD R. W., Jr THROMBOANGIITIS OBLITERANS AND ARTERIOSCLEROSIS OBLITERANS. CLINICAL AND PROGNOSTIC DIFFERENCES. Ann Intern Med. 1963 Sep;59:288–296. doi: 10.7326/0003-4819-59-3-288. [DOI] [PubMed] [Google Scholar]
  11. McLoughlin G. A., Helsby C. R., Evans C. C., Chapman D. M. Association of HLA-A9 and HLA-B5 with Buerger's disease. Br Med J. 1976 Nov 13;2(6045):1165–1166. doi: 10.1136/bmj.2.6045.1165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Mozes M., Cahansky G., Doitsch V., Adar R. The association of atherosclerosis and Buerger's disease: a clinical and radiological study. J Cardiovasc Surg (Torino) 1970 Jan-Feb;11(1):52–59. [PubMed] [Google Scholar]
  13. ORBAN F. New trends in the treatment of thromboangeiosis (Buerger's disease). Ann R Coll Surg Engl. 1961 Feb;28:69–100. [PMC free article] [PubMed] [Google Scholar]
  14. Otawa T., Jugi T., Kawano N., Mishima Y., Toyama H. Letter: HL-A antigens in thromboangiitis obliterans. JAMA. 1974 Nov 25;230(8):1128–1128. doi: 10.1001/jama.230.8.1128. [DOI] [PubMed] [Google Scholar]
  15. Rivera R. Roentgenographic diagnosis of Buerger's disease. J Cardiovasc Surg (Torino) 1973 Jan-Feb;14(1):40–46. [PubMed] [Google Scholar]
  16. SZILAGYI D. E., DERUSSO F. J., ELLIOTT J. P., Jr THROMBOANGIITIS OBLITERANS. CLINICO-ANGIOGRAPHIC CORRELATIONS. Arch Surg. 1964 May;88:824–835. doi: 10.1001/archsurg.1964.01310230100021. [DOI] [PubMed] [Google Scholar]
  17. WESSLER S., MING S. C., GUREWICH V., FREIMAN D. G. A critical evaluation of thromboangitis obliterans. The case against Buerger's disease. N Engl J Med. 1960 Jun 9;262:1149–1160. doi: 10.1056/NEJM196006092622301. [DOI] [PubMed] [Google Scholar]
  18. Welling R. E. Buerger's disease revisited. Angiology. 1982 Apr;33(4):239–250. doi: 10.1177/000331978203300404. [DOI] [PubMed] [Google Scholar]

Articles from Texas Heart Institute Journal are provided here courtesy of Texas Heart Institute

RESOURCES